Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria.

Discussion Even if there is a decreasing trend in the incidence rate of TD, 1 TD at many destinations remains the most frequent health problem abroad in rapidly increasing numbers of travellers. 27 , 28 Only few among these profit of a decreased risk associated with previous exposure to enteric pathogens in low-income countries. 29 Particularly

also in 47,180 other papers